To assess the predictive ability of the model, we constructed time-dependent ROC curves, and the results showed that the CD4 TLAs-related prognostic model had high accuracy in BC patients (Figure 5E; AUC at 1, 3, and 5 years were 0.742, 0.751, and 0.723, respectively). This evidence concerns the gene CD4 and breast cancer.